Organization
Takeshi Morimoto
4 clinical trials
Clinical trial
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without RevascularizationStatus: Recruiting, Estimated PCD: 2030-03-01
Clinical trial
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer StudyStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With CancerStatus: Active (not recruiting), Estimated PCD: 2024-09-30
Clinical trial
GOREISAN for Heart Failure (GOREISAN-HF) TrialStatus: Recruiting, Estimated PCD: 2024-01-01